Kyntra Bio, Inc. · NASDAQ:KYNB
Kyntra Bio, Inc. shareholders
As of Jun 30, 2026, 25 institutions reported holding Kyntra Bio, Inc., 24.7% of its shares. Largest: Armistice Capital, LLC, Vanguard and Acadian Asset Management LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Kyntra Bio, Inc. | Change | Filed |
|---|---|---|---|---|
| Armistice Capital, LLC | 400K | 9.9% | no change | Aug 14, 2026 |
| Vanguard | 185K | 4.6% | +3,506 | Aug 13, 2026 |
| Acadian Asset Management LLC | 106K | 2.6% | no change | Aug 13, 2026 |
| BlackRock | 84,330 | 2.1% | −1 | Aug 7, 2026 |
| Geode Capital | 43,219 | 1.1% | −2,779 | Aug 12, 2026 |
| HighTower Advisors, LLC | 39,746 | 0.98% | +2 | Aug 26, 2026 |
| Two Sigma | 39,511 | 0.98% | −10,000 | Aug 14, 2026 |
| Renaissance Technologies | 27,081 | 0.67% | −400 | Aug 13, 2026 |
| Birchview Capital, LP | 22,566 | 0.56% | no change | Aug 14, 2026 |
| State Street | 20,284 | 0.50% | no change | Aug 7, 2026 |